Header Logo

Connection

Theo Manschreck to Middle Aged

This is a "connection" page, showing publications Theo Manschreck has written about Middle Aged.
Connection Strength

0.224
  1. Manschreck TC, Khan NL. Recent advances in the treatment of delusional disorder. Can J Psychiatry. 2006 Feb; 51(2):114-9.
    View in: PubMed
    Score: 0.025
  2. Manschreck TC, Maher BA, Candela SF, Redmond D, Yurgelun-Todd D, Tsuang M. Impaired verbal memory is associated with impaired motor performance in schizophrenia: relationship to brain structure. Schizophr Res. 2000 May 25; 43(1):21-32.
    View in: PubMed
    Score: 0.017
  3. Manschreck TC, Redmond DA, Candela SF, Maher BA. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia. J Neuropsychiatry Clin Neurosci. 1999; 11(4):481-9.
    View in: PubMed
    Score: 0.015
  4. Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? Schizophr Res. 2018 03; 193:263-268.
    View in: PubMed
    Score: 0.014
  5. Manschreck TC, Redmond DA, Beaudette SM. Clozapine in the back wards. Ann Clin Psychiatry. 1994 Dec; 6(4):215-25.
    View in: PubMed
    Score: 0.012
  6. Buckley PF, Schooler NR, Goff DC, Hsiao J, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz AJ, Miller del D, Severe JB, Wilson DR, Ames D, Bustillo J, Mintz J, Kane JM. Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study. Schizophr Bull. 2015 Mar; 41(2):449-59.
    View in: PubMed
    Score: 0.011
  7. Chun J, Karam ZN, Marzinzik F, Kamali M, O'Donnell L, Tso IF, Manschreck TC, McInnis M, Deldin PJ. Can P300 distinguish among schizophrenia, schizoaffective and bipolar I disorders? An ERP study of response inhibition. Schizophr Res. 2013 Dec; 151(1-3):175-84.
    View in: PubMed
    Score: 0.011
  8. Goff DC, McEvoy JP, Citrome L, Mech AW, Bustillo JR, Gil R, Buckley P, Manschreck TC, Achtyes ED, Macklin EA. High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. J Clin Psychopharmacol. 2013 Aug; 33(4):485-90.
    View in: PubMed
    Score: 0.011
  9. Stroup TS, Appelbaum PS, Gu H, Hays S, Swartz MS, Keefe RS, Kim SY, Manschreck TC, Boshes RA, McEvoy JP, Lieberman JA. Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study. Schizophr Res. 2011 Aug; 130(1-3):47-52.
    View in: PubMed
    Score: 0.009
  10. Manschreck TC, Keuthen NJ, Schneyer ML, Celada MT, Laughery J, Collins P. Abnormal involuntary movements and chronic schizophrenic disorders. Biol Psychiatry. 1990 Jan 15; 27(2):150-8.
    View in: PubMed
    Score: 0.008
  11. Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2008 Feb; 33(3):465-72.
    View in: PubMed
    Score: 0.007
  12. Pollack MH, Manschreck TC. Oculocutaneous albinism and schizophrenia. Biol Psychiatry. 1986 Jul; 21(8-9):830-3.
    View in: PubMed
    Score: 0.007
  13. Maher BA, Manschreck TC, Linnet J, Candela S. Quantitative assessment of the frequency of normal associations in the utterances of schizophrenia patients and healthy controls. Schizophr Res. 2005 Oct 15; 78(2-3):219-24.
    View in: PubMed
    Score: 0.006
  14. Stroup S, Appelbaum P, Swartz M, Patel M, Davis S, Jeste D, Kim S, Keefe R, Manschreck T, McEvoy J, Lieberman J. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. Schizophr Res. 2005 Dec 01; 80(1):1-8.
    View in: PubMed
    Score: 0.006
  15. Manschreck TC, Maher BA, Waller NG, Ames D, Latham CA. Deficient motor synchrony in schizophrenic disorders: clinical correlates. Biol Psychiatry. 1985 Sep; 20(9):990-1002.
    View in: PubMed
    Score: 0.006
  16. Manschreck TC. Psychopathology of motor behavior in schizophrenia. Prog Exp Pers Res. 1983; 12:53-99.
    View in: PubMed
    Score: 0.005
  17. Manschreck TC, Maher BA, Rucklos ME, Vereen DR. Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med. 1982 Feb; 12(1):73-84.
    View in: PubMed
    Score: 0.005
  18. Manschreck TC, Maher BA, Rucklos ME, Vereen DR, Ader DN. Deficient motor synchrony in schizophrenia. J Abnorm Psychol. 1981 Aug; 90(4):321-8.
    View in: PubMed
    Score: 0.005
  19. Manschreck TC, Maher BA, Ader DN. Formal thought disorder, the type-token ratio and disturbed voluntary motor movement in schizophrenia. Br J Psychiatry. 1981 Jul; 139:7-15.
    View in: PubMed
    Score: 0.005
  20. Manschreck TC. The assessment of paranoid features. Compr Psychiatry. 1979 Jul-Aug; 20(4):370-7.
    View in: PubMed
    Score: 0.004
  21. Manschreck TC, Maher BA, Rucklos ME, White MT. The predictability of thought disordered speech in schizophrenic patients. Br J Psychiatry. 1979 Jun; 134:595-601.
    View in: PubMed
    Score: 0.004
  22. Maher BA, Manschreck TC, Yurgelun-Todd DA, Tsuang MT. Hemispheric asymmetry of frontal and temporal gray matter and age of onset in schizophrenia. Biol Psychiatry. 1998 Sep 15; 44(6):413-7.
    View in: PubMed
    Score: 0.004
  23. Manschreck TC, Petri M. The paranoid syndrome. Lancet. 1978 Jul 29; 2(8083):251-3.
    View in: PubMed
    Score: 0.004
  24. Blyler CR, Maher BA, Manschreck TC, Fenton WS. Line drawing as a possible measure of lateralized motor performance in schizophrenia. Schizophr Res. 1997 Jul 25; 26(1):15-23.
    View in: PubMed
    Score: 0.004
  25. Maher BA, Manschreck TC, Redmond D, Beaudette S. Length of illness and the gradient from positive to negative semantic priming in schizophrenic patients. Schizophr Res. 1996 Nov 15; 22(2):127-32.
    View in: PubMed
    Score: 0.003
  26. Jacobson G, Baldessarini RJ, Manschreck T. Tardive and withdrawal dyskinesia associated with haloperidol. Am J Psychiatry. 1974 Aug; 131(8):910-3.
    View in: PubMed
    Score: 0.003
  27. Wilson SN, Surman OS, Colvin R, Ozonoff D, Gelenberg AJ, Jenike MA, Manschreck T, Pato C. Unusual lymphocyte subset distribution in some depressed patients. J Clin Psychiatry. 1990 Feb; 51(2):51-2.
    View in: PubMed
    Score: 0.002
  28. Maher BA, Manschreck TC, Weisstein CC, Schneyer ML, Okunieff R. Cloze analysis in schizophrenic speech: scoring method and raters' education. Percept Mot Skills. 1988 Dec; 67(3):911-8.
    View in: PubMed
    Score: 0.002
  29. Zusky PM, Biederman J, Rosenbaum JF, Manschreck TC, Gross CC, Weilberg JB, Gastfriend DR. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol. 1988 Apr; 8(2):120-4.
    View in: PubMed
    Score: 0.002
  30. Garber HJ, Weilburg JB, Buonanno FS, Manschreck TC, New PF. Use of magnetic resonance imaging in psychiatry. Am J Psychiatry. 1988 Feb; 145(2):164-71.
    View in: PubMed
    Score: 0.002
  31. Zusky P, Manschreck TC, Blanchard C, Rosenbaum J, Elliot C, Lou P. Dothiepin hydrochloride: treatment efficacy and safety. J Clin Psychiatry. 1986 Oct; 47(10):504-7.
    View in: PubMed
    Score: 0.002
  32. Uzogara E, Sheehan DV, Manschreck TC, Jones KJ. A combination drug treatment for acute common migraine. Headache. 1986 May; 26(5):231-6.
    View in: PubMed
    Score: 0.002
  33. Sheehan DV, Davidson J, Manschreck T, Van Wyck Fleet J. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol. 1983 Feb; 3(1):28-31.
    View in: PubMed
    Score: 0.001
  34. Latham C, Holzman PS, Manschreck TC, Tole J. Optokinetic nystagmus and pursuit eye movements in schizophrenia. Arch Gen Psychiatry. 1981 Sep; 38(9):997-1003.
    View in: PubMed
    Score: 0.001
  35. Jacobson AM, Manschreck TC, Silverberg E. Behavioral treatment for Raynaud's disease: a comparative study with long-term follow-up. Am J Psychiatry. 1979 Jun; 136(6):844-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.